Publication

The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model

Find out how PK‑PD modelling shows delayed lipid‑lowering effects driven by key flavonoids in Wendan…

CertaraJanuary 23, 2024

Publication

Population Pharmacokinetics and Individualized Medication of Azithromycin for Injection in Children Under 6 Years Old

Explore how weight and age drive azithromycin PK variability; PopPK modelling supports personalized dosing using…

CertaraJanuary 20, 2024

Blog

Understanding the role of your discovery asset’s target product profile

If you work at a biotechnology start-up, you’re probably excited about your compound assets, particularly…

CertaraJanuary 19, 2024

On-Demand Webinar

Streamlining Your NCA Workflow

PK analysis intended for submission contends with many data and compliance challenges. To work efficiently,…

CertaraJanuary 18, 2024

Publication

Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database

To assess real-world treatment patterns in patients diagnosed with hormone receptor positive (HR+), human epidermal…

CertaraJanuary 17, 2024

Publication

Population pharmacokinetics of rotigotine extended‑release microspheres for intramuscular injection in early‑stage Parkinson’s disease

Discover how body weight meaningfully affects rotigotine ER exposure; race has minimal impact, modelled using…

CertaraJanuary 17, 2024

On-Demand Webinar

Clinical Data Standardization: Achieving Cleaner Data and Faster Regulatory Submissions

Master the essentials of clinical data standardization for regulatory submissions in this best practice webinar:…

CertaraJanuary 16, 2024

Publication

Real-world application of PBPK in drug discovery

The utility of PBPK models in support of drug development has been well documented. During…

CertaraJanuary 11, 2024

Publication

Effect of High-Fat Meal on the Pharmacokinetics and Safety of Valsartan/Amlodipine Fixed Dose Combination Tablets in Healthy Subjects

See how high‑fat meals reduce valsartan exposure by over 50% while amlodipine PK is unaffected,…

CertaraJanuary 11, 2024

Blog

Improving your drug discovery workflow: Collaboration, data management, and security

PPT administration is tedious and unreliable. How to keep track of drug discovery projects efficiently…

CertaraJanuary 10, 2024

The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model

Population Pharmacokinetics and Individualized Medication of Azithromycin for Injection in Children Under 6 Years Old

Understanding the role of your discovery asset’s target product profile

Streamlining Your NCA Workflow

Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database

Population pharmacokinetics of rotigotine extended‑release microspheres for intramuscular injection in early‑stage Parkinson’s disease

Clinical Data Standardization: Achieving Cleaner Data and Faster Regulatory Submissions

Real-world application of PBPK in drug discovery

Effect of High-Fat Meal on the Pharmacokinetics and Safety of Valsartan/Amlodipine Fixed Dose Combination Tablets in Healthy Subjects

Improving your drug discovery workflow: Collaboration, data management, and security

Newsletter sign up

Quick links

Solutions

Contact